| Original language | English |
|---|---|
| Pages (from-to) | e506-e509 |
| Journal | Haemophilia |
| Volume | 27 |
| Issue number | 4 |
| Early online date | 2020 |
| DOIs |
|
| Publication status | Published - Jul 2021 |
Keywords
- bleeding
- bleeding disorder
- desmopressin
- haemophilia A
- pharmacokinetics
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Haemophilia, Vol. 27, No. 4, 07.2021, p. e506-e509.
Research output: Contribution to journal › Comment/Letter to the editor › Academic
TY - JOUR
T1 - The association between desmopressin exposure, FVIII response and side effects
AU - Schütte, Lisette M.
AU - van Hest, Reinier M.
AU - Cnossen, Marjon H.
AU - Stoof, Sara C. M.
AU - Leebeek, Frank W. G.
AU - Mathôt, Ron A. A.
AU - Kruip, Marieke J. H. A.
N1 - Funding Information: L. M. Schütte, R. M. van Hest and S. C. M. Stoof have no conflicts of interest. M. H. Cnossen has received grants from governmental and societal research institutes such as NWO, ZonMW, Innovation fund, from private funds, institutional grants and unrestricted investigator research grants/educational and travel funding from the following companies over the years: Pfizer, Baxter/ Baxalta/ Shire, Bayer Schering Pharma, CSL Behring, Sobi Biogen, Novo Nordisk, Novartis and Nordic Pharma, and has served as a member on steering boards of Roche and Bayer. All grants, awards and fees go to the institution. F. W. G. Leebeek received research funding from CSL Behring, Takeda and uniQure outside the submitted work. He is a consultant for UniQure, Takeda and BioMarin, of which fees go to the institution. He received travel fees from Sobi. He is DSMB member for a study of Roche. R. A. A. Mathôt has received grants from governmental and societal research institutes such as NWO, ZonMW and Innovation fund and unrestricted investigator research grants from Baxter/ Baxalta/ Shire, Bayer Schering Pharma and CSL Behring. He has served as advisor for Bayer, CSL Behring, Merck Sharp & Dohme, Baxter/ Baxalta/ Shire, and Zeria. All grants and fees paid to the institution. M. J. H. A. Kruip received grants from governmental and societal research institutes such as NWO, ZonMW, Innovation fund, institutional grants and unrestricted investigator research grants from Pfizer, Daiichi Sankyo, Boehringer Ingelheim and research plus speakers fee from Bayer. All grants, awards and fees go to the institution.
PY - 2021/7
Y1 - 2021/7
KW - bleeding
KW - bleeding disorder
KW - desmopressin
KW - haemophilia A
KW - pharmacokinetics
UR - http://www.scopus.com/inward/record.url?scp=85097501986&partnerID=8YFLogxK
U2 - 10.1111/hae.14227
DO - 10.1111/hae.14227
M3 - Comment/Letter to the editor
C2 - 33314458
SN - 1351-8216
VL - 27
SP - e506-e509
JO - Haemophilia
JF - Haemophilia
IS - 4
ER -